Friday 31 December 2010

Fentanyl Janssen




Fentanyl-Janssen may be available in the countries listed below.


Ingredient matches for Fentanyl-Janssen



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl-Janssen in the following countries:


  • Peru

  • Tunisia

  • Turkey

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl-Janssen in the following countries:


  • Austria

  • Bangladesh

  • Costa Rica

  • Czech Republic

  • Dominican Republic

  • El Salvador

  • France

  • Germany

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Malta

  • Netherlands

  • Nicaragua

  • Panama

  • Poland

  • Romania

  • Singapore

  • Switzerland

International Drug Name Search

Sunday 26 December 2010

Aciclovir Winthrop




Aciclovir Winthrop may be available in the countries listed below.


Ingredient matches for Aciclovir Winthrop



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Winthrop in the following countries:


  • France

  • Portugal

International Drug Name Search

Friday 24 December 2010

ranibizumab Intraocular


ra-ni-BIZ-oo-mab


Commonly used brand name(s)

In the U.S.


  • Lucentis

Available Dosage Forms:


  • Solution

Therapeutic Class: Ophthalmologic Agent


Pharmacologic Class: Monoclonal Antibody


Uses For ranibizumab


Ranibizumab is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness.


ranibizumab is also used to treat macular edema (swelling of the back of the eye) after retinal vein occlusion (blockage of a blood vessel in the eye).


ranibizumab is available only with your doctor's prescription.


Before Using ranibizumab


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ranibizumab, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to ranibizumab or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of ranibizumab in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ranibizumab in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of ranibizumab. Make sure you tell your doctor if you have any other medical problems, especially:


  • Eye infection or

  • Infection around the eye—Should not be used in patients with these conditions.

  • Glaucoma—Use with caution. May make this condition worse.

Proper Use of ranibizumab


An eye doctor will give you ranibizumab as a shot into the eye.


ranibizumab is usually given once a month (about every 28 days). In some patients, it may be given once every 3 months after the first 4 injections.


Precautions While Using ranibizumab


Your eye doctor will want to check your progress at regular visits, especially during the first few days after you receive ranibizumab.


Serious eye problems may occur with ranibizumab. Check with your eye doctor right away if your eye becomes red, sensitive to light, or painful, or if you have a change in vision several days after you receive ranibizumab. Also, tell your eye doctor if you feel increased pressure in the eye.


ranibizumab may increase your risk of blood clots. Check with your doctor right away if you are having pain in your chest, groin, or legs, especially the calves; difficulty with breathing; a severe, sudden headache; slurred speech; sudden, unexplained shortness of breath; sudden loss of coordination; sudden, severe weakness or numbness in your arm or leg; or vision changes.


ranibizumab Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Blindness

  • bloody eye

  • blurred vision or loss of vision

  • decreased vision or other changes in vision

  • disturbed color perception

  • dizziness

  • double vision

  • dry eye

  • eye pain

  • fainting

  • feeling of having something in the eye

  • halos around lights

  • headache

  • night blindness

  • overbright appearance of lights

  • pain or tenderness around the eyes and cheekbones

  • red, sore eyes

  • redness of the white part of the eyes or inside of the eyelids

  • redness, swelling, or itching of the eyelid

  • seeing flashes or sparks of light

  • seeing floating spots before the eyes, or a veil or curtain appearing across part of vision

  • sensitivity of the eye to light

  • tearing of the eyes

  • tunnel vision

  • watering of the eyes

Less common
  • Body aches or pain

  • chest pain

  • chills

  • cough

  • difficulty with breathing

  • dry mouth

  • fainting

  • fast, slow, or irregular heartbeat

  • general feeling of discomfort or illness

  • head congestion

  • hoarseness, loss of voice, or other voice changes

  • loss of consciousness

  • muscle aches and pains

  • nasal congestion

  • pain in the chest, groin, or legs, especially the calves

  • painful blisters on the trunk of the body

  • pale skin

  • severe, sudden headache

  • shivering

  • shortness of breath

  • slurred speech

  • sneezing

  • sore throat

  • stuffy or runny nose

  • sudden loss of coordination

  • sudden, severe weakness or numbness in the arm or leg

  • sudden, unexplained shortness of breath

  • sweating

  • tightness in the chest

  • trouble sleeping

  • troubled breathing

  • unexplained weight loss

  • unusual tiredness or weakness

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Back pain

  • difficulty having a bowel movement (stool)

  • difficulty with moving

  • muscle stiffness

  • sleeplessness

  • swelling or redness in the joints

  • unable to sleep

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: ranibizumab Intraocular side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More ranibizumab Intraocular resources


  • Ranibizumab Intraocular Side Effects (in more detail)
  • Ranibizumab Intraocular Use in Pregnancy & Breastfeeding
  • Ranibizumab Intraocular Drug Interactions
  • Ranibizumab Intraocular Support Group
  • 1 Review for Ranibizumab Intraocular - Add your own review/rating


Compare ranibizumab Intraocular with other medications


  • Diabetic Retinopathy
  • Macular Degeneration
  • Macular Edema

Reodyn




Reodyn may be available in the countries listed below.


Ingredient matches for Reodyn



Carbocisteine

Carbocisteine is reported as an ingredient of Reodyn in the following countries:


  • Finland

International Drug Name Search

Tuesday 21 December 2010

Anacort




Anacort may be available in the countries listed below.


Ingredient matches for Anacort



Hydrocortisone

Hydrocortisone 21-(hydrogen succinate) (a derivative of Hydrocortisone) is reported as an ingredient of Anacort in the following countries:


  • Bangladesh

International Drug Name Search

Pellagra Medications


Definition of Pellagra: A disease caused by a deficient diet or failure of the body to absorb niacin (one of the B complex vitamins) or an amino acid (tryptophan). Common in certain parts of the world (in people consuming large quantities of corn), the disease is characterized by scaly skin sores, diarrhea, mucosal changes, and mental symptoms (especially a schizophrenia-likedementia). It may develop after gastrointestinal diseases or alcoholism.

Drugs associated with Pellagra

The following drugs and medications are in some way related to, or used in the treatment of Pellagra. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Pellagra





Drug List:

Tuesday 14 December 2010

Clopidogrel-biomo




Clopidogrel-biomo may be available in the countries listed below.


Ingredient matches for Clopidogrel-biomo



Clopidogrel

Clopidogrel besilate (a derivative of Clopidogrel) is reported as an ingredient of Clopidogrel-biomo in the following countries:


  • Germany

International Drug Name Search

Thursday 9 December 2010

Bezafibrato




Bezafibrato may be available in the countries listed below.


Ingredient matches for Bezafibrato



Bezafibrate

Bezafibrato (DCIT) is also known as Bezafibrate (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 5 December 2010

Mitomycin-Kyowa




Mitomycin-Kyowa may be available in the countries listed below.


Ingredient matches for Mitomycin-Kyowa



Mitomycin

Mitomycin is reported as an ingredient of Mitomycin-Kyowa in the following countries:


  • China

International Drug Name Search